De Keersmaecker, K., and Cools, J. (2006). Chronic myeloproliferative disorders: a tyrosine kinase tale. Leukemia 20, 200-205.
Griesinger, F., Janke, A., Podleschny, M., and Bohlander, S.K. (2002). Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line. British journal of haematology 119, 454-458.
Gu, J.J., Ryu, J.R., and Pendergast, A.M. (2009). Abl tyrosine kinases in T-cell signaling. Immunological reviews 228, 170-183.
Iijima, Y., Ito, T., Oikawa, T., Eguchi, M., Eguchi-Ishimae, M., Kamada, N., Kishi, K., Asano, S., Sakaki, Y., and Sato, Y. (2000). A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 95, 2126-2131.
Yagasaki, F., Wakao, D., Yokoyama, Y., Uchida, Y., Murohashi, I., Kayano, H., Taniwaki, M., Matsuda, A., and Bessho, M. (2001). Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation. Cancer research 61, 8371-8374.
Yuan, B.Z., Jefferson, A.M., Popescu, N.C., and Reynolds, S.H. (2004). Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine. Neoplasia (New York, NY) 6, 412-419.